Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,024Cannabis and Cannabinoid ResearchSchizophrenia research and treatmentPsychedelics and Drug Studies

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Open access

Abstract

Recent advances in the understanding of brain cannabinoid receptor function have renewed interest in the association between cannabinoid compounds and psychosis. In a 3-day, double-blind, randomized, and counterbalanced study, the behavioral, cognitive, and endocrine effects of 0, 2.5, and 5 mg intravenous delta-9-tetrahydrocannabinol (Delta-9-THC) were characterized in 22 healthy individuals, who had been exposed to cannabis but had never been diagnosed with a cannabis abuse disorder. Prospective safety data at 1, 3, and 6 months poststudy was also collected. Delta-9-THC (1) produced schizophrenia-like positive and negative symptoms; (2) altered perception; (3) increased anxiety; (4) produced euphoria; (5) disrupted immediate and delayed word recall, sparing recognition recall; (6) impaired performance on tests of distractibility, verbal fluency, and working memory (7) did not impair orientation; (8) increased plasma cortisol. These data indicate that Delta-9-THC produces a broad range of transient symptoms, behaviors, and cognitive deficits in healthy individuals that resemble some aspects of endogenous psychoses. These data warrant further study of whether brain cannabinoid receptor function contributes to the pathophysiology of psychotic disorders.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300496

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 143 references

Research works printed but not linked: 6

  1. Belger A, Puce A, Krystal JH, Gore JC, Goldman-Rakic P, McCarthy G (1998). Dissociation of mnemonic perceptual processes during spatial nonspatial working memory using fMRI. Hum Brain Mapping 6: 14–32. · DOI · Paper page
  2. Gold MS (1991). Marijuana In: Miller eNS (ed). Comprehensive Handbook of Alcohol Drug Addiction. Marcel Decker: New York. pp 353–376.
  3. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K et al (1999b). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544–4558. · DOI · Paper page
  4. Moreau J (1973) In: Peters NGH (ed). Hashish Mental Illness. Raven Press: New York. pp 245.
  5. Moreau de Tours J (1973). Sobre el hachisch y la alienacion mental. Actas Luso-Espanolas Neurol Psiquiatr Cienc Afines 1: 477–484.
  6. Wall ME, Brine DR, Perez-Reyes M (1976). Metabolism of cannabinoids in man In: Braude MC, Szara S (eds). Pharmacology of Marihuana Vol 1, pp 536.

Cited by

See all 1,024

Metadata

Authors
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H.
Affiliations
  • Yale University (US)
  • Nathan Kline Institute for Psychiatric Research (US)
Venue
Neuropsychopharmacology
Published
2004-06-02
Volume
29
Issue
8
Pages
1558-1572
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W1996278273
Cited by
1,024
References
143
Citations by year
2026: 28 · 2025: 24 · 2024: 40 · 2023: 45 · 2022: 66 · 2021: 64 · 2020: 91 · 2019: 50 · 2018: 57 · 2017: 61 · 2016: 58 · 2015: 49 · 2014: 55 · 2013: 36 · 2012: 55
FWCI
12.75
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health (5k02aa000261-04)
  • National Center for PTSD, U.S. Department of Veterans Affairs
  • National Institute on Alcohol Abuse and Alcoholism (K02 AA00261-04)
  • National Institute of Mental Health (R01 MH61019-02, MH 44866, MH61019-02, R01MH061019, P50 MH44866-15, P50MH044866)
  • National Institute on Drug Abuse (R01DA012382, 1 DA12382-01)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords
delta-9-tetrahydrocannabinol, psychotomimetic effects, psychosis, schizophrenia-like symptoms, positive and negative symptoms, cognitive impairment, working memory, distractibility, verbal fluency, plasma cortisol, anxiety, euphoria, altered perception, cannabinoid receptors, cannabis use, healthy volunteers, drug safety
MeSH terms
Adult, Anxiety, Arousal, Attention, Behavior, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Female, Hallucinogens, Hemodynamics, Humans, Hydrocortisone, Injections, Intravenous, Male, Memory, Short-Term, Panic, Prolactin, Psychiatric Status Rating Scales, Psychometrics, Psychoses, Substance-Induced, Mental Recall, Speech, Dronabinol, Verbal Learning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. https://app.cochat.ai/papers/10.1038/sj.npp.1300496
The paper
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004). The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. Neuropsychopharmacology. https://doi.org/10.1038/sj.npp.1300496

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.